MedPath

The investigation for the association between the choleretic effects of Inchinkoto and intestinal microenvironment in patients with obstructive jaundice.

Not Applicable
Conditions
Patients with external biliary drainage due to obstructive jaundice.
Registration Number
JPRN-UMIN000025200
Lead Sponsor
agoya University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
37
Inclusion Criteria

Not provided

Exclusion Criteria

1)Patients with severe complications such as renal, cardiac, hematologic, and metabolic diseases. 2)Patients who are taking "Kampo" within 4 weeks. 3)Patients who are taking choleretic drug within 4 weeks. 4)Patients in pregnant or who expect being pregnant. 5)Patients who are allergic to "Kampo". 6)Patients who are not eligible for this study by investigators' decision.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath